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Summary Forward genetics is a common approach to dissecting complex traits like common human
diseases. The ultimate aim of this approach was the identiﬁcation of genes that are causal
for disease or other phenotypes of interest. However, the forward genetics approach is by
deﬁnition restricted to the identiﬁcation of genes that have incurred mutations over the
course of evolution or that incurred mutations as a result of chemical mutagenesis, and
that as a result lead to disease or to variations in other phenotypes of interest. Genes that
harbour no such mutations, but that play key roles in parts of the biological network that
lead to disease, are systematically missed by this class of approaches. Recently, a class of
novel integrative genomics approaches has been devised to elucidate the complexity of
common human diseases by intersecting genotypic, molecular proﬁling, and clinical data in
segregating populations. These novel approaches take a more holistic view of biological
systems and leverage the vast network of gene–gene interactions, in combination with DNA
variation data, to establish causal relationships among molecular proﬁling traits and
Fbetween molecular proﬁling and disease (or other classic phenotypes). A number of novel
genes for disease phenotypes have been identiﬁed as a result of these approaches, high-
lighting the utility of integrating orthogonal sources of data to get at the underlying causes
of disease.
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Treating DNA variations as markers and testing such
markers in human and experimental populations for co-
segregation with disease or other phenotypes of interest, is
an approach to elucidating complex traits originally pro-
posed by Botstein et al. (1980), which is in widespread use
today. Markers that co-segregate with a disease trait high-
light regions in the genome that are linked to and partially
explain disease susceptibility. Once a genomic region has
been linked to disease, positional cloning strategies and
direct testing of positional candidate genes are employed to
identify the gene or genes of interest predisposing to disease
in the region of interest. Therefore, the primary focus of this
approach is more or less restricted to looking in a single
genome location for a single gene driving a disease trait of
interest, a classic reductionist approach to elucidating
complex systems.
While the identiﬁcation of genes in a region found to be
linked to disease is of high interest, a more general view is
that of genetic loci associated with disease as perturbations
to a biological system that ultimately result in altering the
genomic, transcriptional, proteomic, and/or signalling
networks in a way that increases susceptibility to disease.
The set of genetic perturbations represented in any given
system provide causal anchors that can aid in establishing
causal associations among genes in the biological network,
beyond what can be achieved by correlation data alone.
While the set of genetic perturbations can change from
population to population, different constellations of pert-
urbations can affect common or completely distinct path-
ways that in turn lead to susceptibility to a common
disease. Viewed in this way, what becomes most important
in elucidating disease traits is not necessarily the identiﬁ-
cation of the genes that give rise to genetic linkages to
disease, but instead the detection of the effects such pert-
urbations have on the various biological networks driving
disease.
Considering large-scale molecular proﬁling traits (tran-
scriptomic, metabolomic, proteomic and so on), together
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traits, leads to a more holistic view of the biological system
under study with respect to disease. Instead of focusing only
on the discovery of a single gene at the disease susceptibility
locus, the genetic loci are considered as perturbations to the
biological network, potentially highlighting whole classes of
genes that may serve as key drivers of disease. Until
recently, considering large-scale molecular proﬁling traits
together with genetic linkages/associations to these and
disease traits was not possible given the functional genomics
technologies needed to take a comprehensive look at the
gene networks were lacking. However, the last 10 years has
seen an explosion of large-scale, high throughput functional
genomics technologies that have motivated a rapid para-
digm shift towards a more systems-level view of biology
(Hartwell et al. 1999; Schadt et al. 2005b). With new tools
now available to look at interactions among tens of thou-
sands of genes in different tissues and in different states, the
completion of the sequencing of the genome of a plethora of
organisms, and a growing computational infrastructure
that enables integrated views of DNA, RNA, metabolomic,
and protein interaction data to elucidate the fundamental
nature of disease and living systems more generally, success
in biomedical research in the future will likely demand a
more comprehensive view of the complex array of interac-
tions in biological systems. How such interactions are
inﬂuenced by genetic background, infection, environmental
states, lifestyle choices and social structures more generally
will also be important (Zerhouni 2003; Barabasi & Oltvai
2004; Schadt et al. 2005b).
Several groups have recently leveraged these technologies
to study the genetic architecture of gene and protein
expression traits and have begun to tease apart the complex
network of interactions associated with complex traits
(Brem et al. 2002, 2005; Schadt et al. 2003, 2005a; Bys-
trykh et al. 2005; Chesler et al. 2005; Ghazalpour et al.
2005; Mehrabian et al. 2005; Zhu et al. 2004). Here I dis-
cuss three novel integrative genomics strategies that have
been applied to mouse F2 intercross populations to identify
susceptibility genes for a number of metabolic traits. The
early successes achieved in these and other similar studies
suggest that a more integrative genomics approach to dis-
secting disease traits will signiﬁcantly enhance the identiﬁ-
cation of key drivers of disease beyond what could be
achieved by genetics alone.
Integrating genotypic, molecular proﬁling and
clinical data to infer causal associations
among traits
Several groups have recently described combining geno-
typic data with molecular proﬁling data to elucidate com-
plex traits, where one of the primary aims is the
identiﬁcation of molecular proﬁling traits and classic phe-
notypes that are associated with common DNA loci in a
given population of interest (Brem et al. 2002, 2005;
Schadt et al. 2003, 2005a; Bystrykh et al. 2005; Chesler
et al. 2005; Ghazalpour et al. 2005; Mehrabian et al.
2005; Zhu et al. 2004). Molecular proﬁling traits, like
many classic phenotypes, are complex, resulting from
complex interactions among a number of genes and
environment (Schadt et al. 2003, 2005a; Brem et al. 2005;
Doss et al. 2005). We have also recently demonstrated that
DNA variations that lead to changes in expression that in
turn lead to disease susceptibility, can be distinguished in
many instances from cases in which DNA variations lead
to changes in disease that in turn lead to changes in
expression (Schadt et al. 2005a). This is perhaps one of the
primary utilities of leveraging genotypic and gene expres-
sion data simultaneously, given that genotypic data pro-
vides a causal anchor that can be used to enhance the
ability to infer causal relationships among complex traits of
interest. Towards this end, a statistical procedure to
establish the relationship among traits driven by common
genetic loci was recently developed (Schadt et al. 2005a).
When two traits of interest are found to be under the
control of a single genetic locus, Fig. 1 depicts the three
basic relationships that are possible between the two traits.
The observed correlations between any two traits in addi-
tion to the correlations between these traits and genotypes
at the given locus, are the key ingredients to inferring the
most likely relationship between the traits. As we have
previously described (Schadt et al. 2005a), likelihoods for
each model can be ﬁt or conditional correlations computed
to identify which of the three models in Fig. 1 best ﬁts the
data, where the best ﬁtting model represents the most
likely relationship between the traits.
This procedure was applied to identify genes that were
causal for obesity traits in an F2 intercross constructed from
the B6 and DBA strains of mice (referred to here as the BXD
cross) (Schadt et al. 2003, 2005a). A number of genes were
strongly predicted as causal for this trait, and from the
candidate causal gene set three genes were selected for
validation via the construction of knockout and transgenic
mice. All three genes were validated in this study (Schadt
et al. 2005a). This represents one of the ﬁrst applications of
a more network-based view of genetics in which causal
genes were identiﬁed not because their underlying genomic
sequence harboured mutations that led directly to disease,
but because mutations in other genes (those genes giving
rise to the obesity QTL in the cross – see Fig. 2) led to
changes in the expression of these three genes, and those
expression changes were found to be causally associated
with the obesity trait.
The procedure to order one gene relative to another
using gene expression and genotypic data can be more
systematically applied to hundreds or even thousands of
traits to reconstruct whole gene networks (Zhu et al.
2004). Figure 2 illustrates how QTL information over
multiple gene expression traits (or any other molecular
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trait with respect to other gene expression traits. Recon-
structing such networks that are predictive provide a ri-
cher context within which to interpret the action of any
one gene in the context of a complex disease trait (Zhu
et al. 2004; Schadt et al. 2005b).
Applying human linkage and ﬁne mapping
strategies in experimental crosses to map
genes for complex traits
Leveraging experimental mouse crosses such as an F2
intercross has limitations when it comes to identifying the
L T2 T1 L T2 T1 L
T1
T2
Avy
eumelaninRNAs
obesity
db/db ob/ob obesity leptin leptin obesity
Causal model Reactive model Independent model
DNA Locus controlling RNA levels and/or clinical traits
R:   Quantitative trait 1 
C:   Quantitative trait 2
L
T1
T2
Figure 1 Possible simple relationships between two quantitative traits (T1 and T2) that are at least partially driven by a common genetic locus (L).
Relative to T1, the Causal Model represents the simplest causal relationship of a single QTL, L, for the trait T2, where L acts on T2 through trait
T1. The ob/ob mouse exempliﬁes this case, where leptin deﬁciency leads to obesity. The Reactive Model is the simplest reactive diagram for a
single QTL, L, for the trait T2, where in this case the expression of gene T1 is responding to T2. The db/db mouse ﬁts this relationship, as in this
animal model leptin levels increase in response to obesity. The Independent Model results when the QTL, L, is causative for the trait T1 as well as
the trait T2, but acts on these traits independently, where T1 and T2 may be correlated for reasons other than the common QTL. The A
y mouse
provides an example of this relationship as the mutation causes decreased levels of eumelanin RNAs levels and independently gives rise to obesity.
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Figure 2 Inferring networks using molecular proﬁling and QTL data. The QTL data can be used to enhance the ordering of gene expression traits into
simple networks. As an example, the left panel represents the simplest case where gene expression trait A gives rise to a cis-acting eQTL and is
correlated with gene expression trait B. Gene expression trait B in turn gives rise to a trans-acting eQTL that is coincident with the cis eQTL for gene
A. This pattern can be analysed as detailed in Fig. 1 to infer that expression variations in gene A lead to expression variations in gene B. A more
complicated example is depicted in the right panel. Here gene expression trait C gives rise to a cis eQTL, and gene expression trait D gives rise to two
trans-acting eQTLs. Gene expression traits C and D are also observed to be correlated with gene expression trait E. Further, gene expression trait E is
also observed to give rise to three trans eQTL that overlap the gene C and D eQTLs. Generalizations of the arguments given in Fig. 1 can be applied
to infer that this pattern suggests that expression variations in genes C and D independently lead to variations in gene E. It is of note in this example
that even though gene D does not harbour mutations that directly affect is function, gene D is still identiﬁed as causal for gene E because DNA
variations in other genes affect gene D’s activity, which in turn affects gene E’s activity. This type of reasoning can be systematically applied to all
genes to reconstruct gene networks, as previously described (Zhu et al. 2004).
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illustrates one approach that can get around this problem
by identifying trans-acting expression QTL (eQTL) that
overlap disease-related QTL, and by using these observa-
tions to infer causal associations. Another technique,
termed in silico QTL mapping, has also recently been pro-
posed as a method to more efﬁciently map genes for disease
(Grupe et al. 2001; Liao et al. 2004). This approach utilizes
population-level disequilibrium among speciﬁc inbred lines
of mice to identify loci associated with disease traits or other
complex phenotypes of interest. While several studies have
been published highlighting the utility of this approach in
the inbred lines of mice (Grupe et al. 2001; Liao et al. 2004),
several recent studies have highlighted strong linkage dis-
equilibrium among unlinked markers operating in this
population of mice (Cervino et al. 2005; Petkov et al. 2005).
Nonrandom association of alleles between unlinked markers
is a well-known phenomenon in human genetic studies, but
only recently has been identiﬁed as a signiﬁcant problem in
carrying out genome-wide association studies in inbred
mouse populations (Cervino et al. 2005). Clustered samp-
ling, epistatic interactions among two or more loci, and
population admixture are all well recognized mechanisms
that can lead to this behaviour (Ott 1999), which in turn
can lead to spurious genetic associations.
To address this problem and to enhance the utility more
generally of the association-based studies carried out in
inbred lines of mice, we proposed a combination linkage and
association approach that incorporated molecular proﬁling
data to identify genes responsible for a given linkage (Cer-
vino et al. 2005). The process is similar to genetic studies
commonly carried out in human populations and begins
with the identiﬁcation of a region in the genome linked to a
disease or other phenotype of interest in an experimental
cross. Identifying a region linked to disease in an experi-
mental cross circumvents the problem of spurious associ-
ation to disease that can arise because of linkage
disequilibrium among unlinked loci. By leveraging haplo-
type information that now exists over many strains, the
regions found to be linked to disease can be further nar-
rowed by looking for shared haplotypes among strains of
mice if the linkage is supported in multiple crosses (Cervino
et al. 2005). Genetic association testing can then be carried
out in the narrowed region using the population of inbred
lines to identify the gene or genes that at least partially
explain the speciﬁc linkage to disease. We have further
enhanced this process by incorporating the type of genetics
of gene expression approach discussed above. That is, if
genes physically residing in the narrowed linkage region
give rise to eQTL that co-localize with the physical gene
location [cis eQTL (Schadt et al. 2003; Doss et al. 2005)],
give rise to expression values that are correlated with the
disease trait, and that test as causal for the disease with
respect to the linkage region of interest, they are identiﬁed
as primary candidate susceptibility genes for disease. This
set of genes then becomes the primary set of candidate genes
driving the disease.
We applied this approach to the BXD cross, a separate F2
intercross populations constructed from the B6 and C3H
strains of mice (referred to here as the BXH cross) and to 62
inbred lines of mice, and mapped Insig2 as a key cholesterol
gene and as a gene associated with a number of other
metabolic traits, including fat mass and insulin levels. After
identifying a chromosome 1 region in the BXH cross that
was linked to total plasma cholesterol levels, insulin levels
and fat mass, Insig2 was subsequently identiﬁed as a gene
falling in this linkage region and giving rise to a very sig-
niﬁcant cis eQTL, with Insig2 expression also supported as
causal for the cholesterol trait. These observations were
subsequently conﬁrmed in a second cross (the BXD cross
described herein). After identifying all SNPs in the linkage
region from a panel of more than 12 000 SNPs, only three
SNPs were found to associate with cholesterol levels in a
broader set of inbred mice over multiple studies involving
cholesterol measures. All three SNPs were in the vicinity of
Insig2. Given the preponderance of evidence from the
crosses, the expression data, the eQTL/causality tests, and
the association results, we claimed Insig2 as at least one of
the susceptibility genes for cholesterol levels and other
metabolic traits supporting the chromosome 1 linkage to
these traits. Interestingly, after publication of our Insig2
ﬁndings, an independent group identiﬁed human DNA
variations in Insig2 that associated with body mass index
(BMI) in multiple human populations, explaining a signiﬁ-
cant proportion of lifetime BMI in the human population
(Alan Herbert, personal communication, ASHG Meetings,
Salt Lake City, Utah, October 2005). These human genetic
results nicely conﬁrm the connection we established in mice
between Insig2 and metabolic traits.
Forward genetics in reverse
Another recently developed integrative genomics approach
to mapping disease genes combines forward and backward
genetics approaches in a way that minimizes the deﬁciencies
of each by leveraging off of their respective strengths (Lum
et al. 2005; Mehrabian et al. 2005). Like the integrative
genomics approaches just described, this novel approach
views QTLs as perturbation events capable of altering the
transcriptional network in a given tissue, where the per-
turbation to the transcriptional network (the transcriptional
ﬁngerprint) is assessed by identifying those gene expression
traits that link to the QTL region of interest. We proposed
that the gene or genes in the QTL region of interest
responsible for such a transcriptional ﬁngerprint induced by
the QTL perturbation event, could in fact be identiﬁed by
perturbing candidate genes in the QTL region in independ-
ent systems and assessing the transcriptional responses. If
the transcriptional ﬁngerprint left by one of these single
gene perturbation events matches the ﬁngerprint induced
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was strong evidence that such a gene at least partially
explained the QTL.
This approach was employed to identify 5-lipoxygenase
(Alox5) as a susceptibility gene for obesity, cholesterol and
bone traits in the BXD cross (Mehrabian et al. 2005). This
followed the identiﬁcation of a hot spot eQTL region on
chromosome6intheBXDcrossthatwasalsoassociatedwith
a number of clinical traits, including fat mass, bone density,
and plasma cholesterol, insulin and leptin levels. Peroxisome
proliferative activated receptor gamma (Pparg) had been
considered a favoured positional candidate in this region,
given that Pparg perturbations lead to variations in many of
these same metabolic phenotypes. However, not only did
Pparg fall in a haplotype shared by the two founding inbred
strains (B6 and DBA) for the BXD cross, but the transcrip-
tional ﬁngerprint induced by Pparg-speciﬁc perturbations
(rosiglitazone treatments and Pparg transgenic mice) did not
signiﬁcantlymatchthetranscriptionalﬁngerprintinducedby
the chromosome 6 QTL in the BXD cross. On the other hand,
the transcriptional ﬁngerprint for the Alox5-speciﬁc pertur-
bation (Alox5 knockout mice) did signiﬁcantly match
(Mehrabianet al.2005).Thistypeofprocedureleveragesour
ability to monitor perturbations in the transcriptional net-
work to map disease genes rapidly and efﬁciently. In fact, one
can imagine constructing single-gene perturbation compen-
dia in different cell types using RNAi-based technologies, and
then using these compendia as a screening tool to isolate
genes that may be responsible for QTL-based transcriptional
perturbations in experimental crosses and beyond.
Conclusion
Classic forward genetic approaches for dissecting complex
traits are based on a reductionist approach to elucidating
complex systems that are typically focused on single genes
or proteins. For Mendelian traits this approach has achieved
great success, but success in the common human diseases
has been plagued by a great many cases in which associa-
tions have failed to replicate across human populations and
QTLs have failed to reproduce across different experimental
crosses, in addition to many other issues that have pre-
vented greater success in the ﬁeld. However, that pheno-
typically similar populations will not reproduce linkages
and/or associations for a particular complex trait is perhaps
to be expected, as multiple perturbations in the genetic
network can affect related or completely distinct pathways
that ultimately lead to the same disease. Genetic perturba-
tions underlying disease in a given population represent just
one of many ways biological networks may be perturbed in
ways that lead to disease or other complex traits of interest.
However, it is likely that there are many key nodes in bio-
logical networks that associate with disease but that, in fact,
harbour no common DNA variations in human or other
populations that predispose to common forms of disease.
HMG-CoA reductase is an excellent example of a gene for
which no common DNA variations have been found that
associate with plasma cholesterol levels in human popula-
tions (Garcia et al. 2001), even though this gene is well
known to play a central role in cholesterol homeostasis and
is the target of statin therapies.
The integrative genomics approaches discussed herein are
not limiting in this same way. Integrating genetic and
molecular proﬁling data allows one to capture the constel-
lation of perturbations because of variations in DNA that
affect portions of the gene network that in turn lead to
disease. That is, while there may only be a single gene
underlying a given linkage to disease, such perturbation
events may in turn cause transcript abundances of hun-
dreds of genes to change, and many of these same genes
may capture information from multiple genetic loci associ-
ated with the same disease. This in fact was the case for
each of the three genes (Tgfbr2, C3ar1 and Zfp90)w e
recently reported as being causal for obesity in the BXD cross
(Schadt et al. 2005a). Combining the genetic and molecular
proﬁling data allows for a much broader net to be cast over
the set of molecular changes associated with disease,
potentially providing for signiﬁcantly increased power to
detect causal associations to disease than could otherwise be
achieved using only the genetic or molecular proﬁling data.
The more systematic application of causality-like argu-
ments can be used to reconstruct whole networks (Fig. 2),
where the networks provide a context in which to interpret
key genes identiﬁed for disease (Zhu et al. 2004; Schadt
et al. 2005b). From the standpoint of treating disease, the
utility of these predictive networks includes reﬁning the
deﬁnition of disease, identifying multiple drug targets that
are causal for a given disease, and prioritizing those targets
based on the extent of causal association to disease, in
addition to the extent of causal association with co-morbi-
dities of the disease or with adverse events that may ensue
in targeting a given pathway with pharmaceutics. Achiev-
ing this level of understanding of disease has the potential to
move us away from the one drug ﬁts all paradigm that
dominates the pharmaceutical landscape at present, and to
instead deliver on the personalized medicine promise of
getting the right drug to the right person at the right time.
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